{"id":"NCT00446511","sponsor":"Novartis Pharmaceuticals","briefTitle":"Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension","officialTitle":"An Extension to Study Protocol CVAL489K2302 to Evaluate the Long Term Safety, Tolerability and Efficacy of Valsartan in Children 6 to 17 Years of Age With Hypertension, Versus Enalapril Treatment for 14 Weeks, or Combined With Enalapril Versus Enalapril for 66 Weeks in Chronic Kidney Disease Patients.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-06","primaryCompletion":"2009-06","completion":"2009-06","firstPosted":"2007-03-13","resultsPosted":"2011-06-06","lastUpdate":"2011-07-12"},"enrollment":250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Valsartan","otherNames":[]},{"type":"DRUG","name":"Enalapril","otherNames":[]},{"type":"DRUG","name":"placebo matched to enalapril","otherNames":[]},{"type":"DRUG","name":"placebo matched to valsartan","otherNames":[]}],"arms":[{"label":"CKD patients: Valsartan+enalapril","type":"EXPERIMENTAL"},{"label":"CKD patients: Enalapril","type":"ACTIVE_COMPARATOR"},{"label":"Non-CKD patients: Valsartan","type":"EXPERIMENTAL"},{"label":"Non-CKD patients: Enalapril","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this extension study is to compare the long-term safety of valsartan versus enalapril, and the effectiveness of the combination of valsartan and enalapril versus enalapril alone in children with hypertension.","primaryOutcome":{"measure":"Number of Patients With Adverse Events","timeFrame":"Start of extension (week 13) to end of study (Week 26 in non-CKD patients and Week 50 in CKD patients)","effectByArm":[{"arm":"CKD Patients: Valsartan+Enalapril","deltaMin":16,"sd":null},{"arm":"CKD Patients: Enalapril","deltaMin":11,"sd":null},{"arm":"Non-CKD Patients: Valsartan","deltaMin":51,"sd":null},{"arm":"Non-CKD Patients: Enalapril","deltaMin":53,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":8},"locations":{"siteCount":9,"countries":["United States","Belgium","France","Germany","Hungary","India","Italy","Poland","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":21},"commonTop":["Headache","Pharyngitis","Nasopharyngitis","Pyrexia","Hyperkalaemia"]}}